Antibody arrays: an embryonic but rapidly growing technology
- PMID: 12546881
- DOI: 10.1016/s1359-6446(02)02413-3
Antibody arrays: an embryonic but rapidly growing technology
Abstract
Protein arrays are now an attractive proposition as they can measure a diverse range of protein interactions not possible with traditional DNA arrays. Antibody arrays are a specific subset of this technology. Originally conceived as multi-analyte detectors, antibody arrays are now used in a wide variety of applications. For instance, the potential of this technology to diagnose human diseases, such as leukemia, breast cancer and, potentially, heart failure, has stimulated much interest. Furthermore, identification of new protein targets in particular disease states will prove to be an invaluable tool in drug discovery and development. Patient prognosis and treatment are also potential applications of the technology. Antibody arrays have proved to be dynamic in response to these broad range of possibilities. This review examines variations in antibody array design and discusses current and potential applications of this novel and interesting technology.
Similar articles
-
The promise of cytokine antibody arrays in the drug discovery process.Expert Opin Ther Targets. 2005 Jun;9(3):601-15. doi: 10.1517/14728222.9.3.601. Expert Opin Ther Targets. 2005. PMID: 15948677 Review.
-
Applications of antibody array platforms.Curr Opin Biotechnol. 2006 Aug;17(4):415-21. doi: 10.1016/j.copbio.2006.06.013. Epub 2006 Jul 11. Curr Opin Biotechnol. 2006. PMID: 16837184 Review.
-
Integration of Antibody Array Technology into Drug Discovery and Development.Assay Drug Dev Technol. 2018 Feb/Mar;16(2):74-95. doi: 10.1089/adt.2017.808. Epub 2018 Feb 2. Assay Drug Dev Technol. 2018. PMID: 29394094 Review.
-
Antibody arrays in biomarker discovery.Adv Clin Chem. 2015;69:255-324. doi: 10.1016/bs.acc.2015.01.002. Epub 2015 Feb 26. Adv Clin Chem. 2015. PMID: 25934364 Review.
-
Cytokine antibody arrays: a promising tool to identify molecular targets for drug discovery.Comb Chem High Throughput Screen. 2003 Dec;6(8):769-75. doi: 10.2174/138620703771826946. Comb Chem High Throughput Screen. 2003. PMID: 14683482 Review.
Cited by
-
High seroprevalence of Borrelia miyamotoi antibodies in forestry workers and individuals suspected of human granulocytic anaplasmosis in the Netherlands.New Microbes New Infect. 2014 Sep;2(5):144-9. doi: 10.1002/nmi2.59. Epub 2014 Sep 6. New Microbes New Infect. 2014. PMID: 25356364 Free PMC article.
-
State of the art in tumor antigen and biomarker discovery.Cancers (Basel). 2011 Jun 9;3(2):2554-96. doi: 10.3390/cancers3022554. Cancers (Basel). 2011. PMID: 24212823 Free PMC article.
-
Application of physicochemically modified silicon substrates as reverse-phase protein microarrays.J Proteome Res. 2009 Mar;8(3):1247-54. doi: 10.1021/pr800455y. J Proteome Res. 2009. PMID: 19170514 Free PMC article.
-
Nanomedicine--challenge and perspectives.Angew Chem Int Ed Engl. 2009;48(5):872-97. doi: 10.1002/anie.200802585. Angew Chem Int Ed Engl. 2009. PMID: 19142939 Free PMC article. Review.
-
Current awareness on comparative and functional genomics.Comp Funct Genomics. 2003;4(2):277-84. doi: 10.1002/cfg.227. Comp Funct Genomics. 2003. PMID: 18629117 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
